Clinical Trial Update: Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine [Phase 2]

View source ↗

Summary

Phase 2 pilot study assessing two strengths of DFN-11 injection for rapidly escalating migraine has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rapidly Escalating Migraine

Drugs mentioned

• DFN-11

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Rapidly Escalating Migraine | Phase 2 | Status: COMPLETED | Results posted: 2018-07-24